|
|
|
|
Direct Cost |
Indirect Cost |
|
| 1OT2CA297204-01 |
MATCHMAKERS: Large-scale generation of TCR-pMHC pairs from naturally occurring sources. |
TECHNICAL UNIVERSITY OF MUNICH |
NCI |
$191,844 |
|
$191,844 |
| 1OT2CA297205-01 |
PROSPECT - Microbiome Studies. (PATHWAYS, RISK FACTORS, AND MOLECULES TO PREVENT EARLY-ONSET COLORECTAL TUMOURS) |
UNIVERSITY OF TRENTO |
NCI |
$134,258 |
$0 |
$134,258 |
| 1OT2CA297206-01 |
MATCHMAKERS |
NETHERLANDS CANCER INSTITUTE |
NCI |
$167,757 |
|
$167,757 |
| 1OT2CA297289-01 |
PROSPECT: Pathways, Risk factors, and mOleculeS to Prevent Early-onset Colorectal Tumors |
KING'S COLLEGE LONDON |
NCI |
$308,605 |
$24,688 |
$333,293 |
| 1OT2CA297382-01 |
PROTECT - Harnessing PROTEin degradation for Advanced Childhood Tumors |
PRINSES MAXIMA VOOR KINDERONCOLOGIE, BV |
NCI |
$86,618 |
$0 |
$86,618 |
| 1OT2CA297417-01 |
C07 - Societal, Ancestry, Molecular and Biological Analyses of Inequalities: SAMBAI |
KING'S COLLEGE LONDON |
NCI |
$92,284 |
$7,383 |
$99,667 |
| 1OT2CA297465-01 |
SAMBAI: Societal, Ancestry, Molecular and Biological Analyses of Inequalities - University of Glasgow |
UNIVERSITY OF GLASGOW |
NCI |
$52,052 |
$3,966 |
$56,018 |
| 1OT2CA297466-01 |
PROTECT (Harnessing PROTEin degradation for Advanced Childhood Tumors) |
UNIVERSITY COLLEGE LONDON |
NCI |
$93,033 |
$7,443 |
$100,476 |
| 1OT2CA297505-01 |
Societal, Ancestry, Molecular and Biological Analyses of Inequalities: SAMBAI |
UNIVERSITY OF NOTTINGHAM |
NCI |
$64,751 |
$5,180 |
$69,931 |
| 1OT2CA297509-01 |
MATCHMAKERS - large-scale generation of reactive TCR-pMHC pairs from human NSCLC |
UNIVERSITY COLLEGE LONDON |
NCI |
$156,741 |
$12,539 |
$169,280 |
| 1OT2CA297513-01 |
MATCHMAKERS - SOLVING TCR RECOGNITION AND DESIGN VIA INTEGRATED HIGH-THROUGHPUT SCREENING, STRUCTURAL, FUNCTIONAL, AND COMPUTATIONAL APPROACHES |
OSLO UNIVERSITY HOSPITAL, RIKSHOSPITALET |
NCI |
$74,043 |
|
$74,043 |
| 1OT2CA297567-01 |
SAMBAI: SOCIETAL, ANCESTRY, MOLECULAR AND BIOLOGICAL ANALYSES OF INEQUALITIES (CGC) |
EUROPEAN MOLECULAR BIOLOGY LABORATORY |
NCI |
$186,220 |
$14,898 |
$201,118 |
| 1OT2CA297568-01 |
PROTECT - Harnessing PROTEin Degradation for Advanced Childhood Tumours |
GERMAN CANCER RESEARCH CENTER |
NCI |
$506,676 |
$0 |
$506,676 |
| 1OT2CA297644-01 |
PROTECT - Harnessing PROTEin degradation for Advanced Childhood Tumors |
UNIVERSITY OF OXFORD |
NCI |
$94,044 |
$7,524 |
$101,568 |
| 1OT2CA297824-01 |
PROTECT - Develop therapeutics to target oncogenic drivers of solid tumours in children |
THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL |
NCI |
$119,133 |
$9,531 |
$128,664 |
| 1R01AG084672-01A1 |
The TMEM106B-GRN-TDP43 triad: leveraging human samples and humanized models to unravel FTLD-TDP disease mechanisms |
FLANDERS INTERUNIV INST BIOTECHNOLOGY |
NIA |
$498,500 |
$39,880 |
$538,380 |
| 1R01AG087902-01 |
Social Modifiers of Primate Lifespan |
UNIVERSITY OF EXETER |
NIA |
$652,684 |
$17,640 |
$670,324 |
| 1R01AI177101-01A1 |
High Dose Oral Rifampicin to Improve Survival from Adult Tuberculous Meningitis: a pharmacokinetic substudy (HARVEST-PK) |
STICHTING RADBOUD UNIVERSITAIR MEDISCH CENTRUM I.O. |
NIAID |
$545,638 |
$15,383 |
$561,021 |
| 1R01AI181733-01A1 |
A secure analytics platform to study the prognosis of people with HIV in the USA, Canada and Europe and comparative effectiveness of treatment regimens: the Antiretroviral Therapy Cohort Collaboration |
UNIVERSITY OF BRISTOL |
NIAID |
$460,434 |
$34,198 |
$494,632 |
| 1R01AI185558-01 |
The role of placental macrophages in cytomegalovirus infection at the maternal-fetal interface |
IMPERIAL COLLEGE OF SCIENCE, TECHNOLOGY AND MEDICINE |
NIAID |
$399,444 |
$31,160 |
$430,604 |